Tooth InjuriesNCT03045185
Regenerative Endodontic Treatment of Traumatised Teeth
A study testing RET using Ciprofloxacin 100mg, and Metronidazole 100mg. in people with Tooth Injuries and Endodontically Treated Teeth, run by University of Leeds.
Trial summary
Aim: The aim of this prospective study was to evaluate the treatment outcomes of regenerative endodontic technique (RET) for the management of traumatised non-vital immature teeth in children. Read more about this study
- Who is it for?
- Ages 6 to 16 yearsHealthy volunteers can take part
- Conditions the study is for
- Tooth Injuries, Endodontically Treated Teeth
- What is being tested?
- RET using Ciprofloxacin 100mg, and Metronidazole 100mg.
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 15 participants
- Where
- No sites listed yet
- Study dates
- 1 Jan 2013to 1 Jan 2017
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 6 to 16 years
- All sexes
- Healthy volunteers accepted
- Child
Who may be able to join
- Patients aged 6-16 years of age
- Patients who are fit and healthy or with an ASA1 or ASA2 medical conditions
- Patients with cooperation level that would allow treatment under local analgesia
- Patients with a traumatised permanent incisors, canines or premolars having at least one of the following:
- Necrotic or partially necrotic root canal systems.
- Periapical periodontitis/abscess.
- Sinus tract.
- Patients with permanent incisors, canines or premolars that have incomplete root formation with open apices.
Who cannot join
- Patient older than 16 year of age
- Patients allergic to Ciprofloxacin, Metronidazole.
- Patients with medical conditions and/or receiving medications that would affect patients' body's ability to heal such as diabetic patients or ability of the patients' blood to clot such as patients with Von Willebrand's disease.
- Patients with risk of developing infective endocarditis or immune compromised patients.
- Patients with non traumatised non-vital permanent incisors, canines or premolars where root development already deemed to be completed.
- No concurrent signs of other pathological root resorption, such as replacement root resorption, which could otherwise affect the prognosis of the tooth.
- Uncooperative patients.
About this study
Official title: A Prospective Clinical Study of Regenerative Endodontic Treatment of Traumatised Non-vital Immature Teeth Using Bi-antibiotic Paste
Aim: The aim of this prospective study was to evaluate the treatment outcomes of regenerative endodontic technique (RET) for the management of traumatised non-vital immature teeth in children. Methodology: This study aims to recruit 25-30 healthy children with traumatised non-vital immature upper incisors to be treated with bi-antibiotic regenerative endodontic technique. Patients will be reviewed clinically at 3m,6m,9m,12m,2y,and 3 years and radiographically at 3m,9m, 2y,and 3 years. One operator will undertake all treatments, clinical reviews and standardised radiographic exposures. Radiographic analysis will be carried out by two calibrated experienced clinicians. Standardised photographs will be taken at 3m,12m,2y,and 3 years and crown colour changes will be assessed using a standardised validated methodology.
Read the detailed description
Aims of the pilot study:
Primary:
- Study the clinical and radiographic success of Regenerative Endodontic Technique for the regeneration/revascularisation of immature permanent teeth with necrotic root canal systems following a traumatic injury.
- Study the qualitative and quantitative increase in root dimensions, following RET, by evaluating continued root development and thickening of dentinal walls.
Secondary:
Evaluate effect of treatment on colour change of the treated tooth compared with the healthy contralateral tooth.
Hypothesis:
Through the repopulation of the root canal space with vital tissue, Regenerative Endodontic Technique would promote continued root development and/or thickening of the dentinal walls, thereby improving the long-term prognosis of non vital immature traumatised teeth.
Methodology:
Design of the pilot study:
This will be a prospective interventional study.
Participants:
This study aims to recruit 25-30 patients. This estimation is based on discussion with the statistician and an estimation of the number of children who are referred to the LDI with non-vital immature anterior teeth following trauma, who might be eligible for participation in the study. Ethical approval will be sought through the Integrated Research Application System (IRAS). Patients referred to the Paediatric Dentistry Department at the Leeds Dental Institute (LDI) will be assessed by the clinicians for suitability for inclusion into this study based on the following inclusion and exclusion criteria.
Intervention:
At the RET clinic and once an informed consent is obtained, the treatment will be carried out over two visits each lasting about 45 minutes. During these visits, patients received the following treatment:
First Treatment Visit:
- Preoperative photographs will be taken by the principal investigator using a Fujifilm (Tokyo, Japan), Finepix S3 Pro camera with 105-mm Micro Nikon (Tokyo, Japan) f2.8 lens and sigma ring flash, EM-140DG.
- The tooth will be isolated using dry dam (Directa, Upplands Visby, Sweden).
- The tooth will be accessed and the pulp will be extirpated. The root canal system will then be irrigated with copious chemical disinfectant ( 0.5% sodium hypochlorite) for 15 minutes.
- The canal will then be negotiated with minimal or no filing to prevent further weakening of the existing dentinal walls.
- The canal will then be dried using paper points.
- In an ante-room, the two antibiotics, Ciprofloxacin and Metronidazole, will be mixed with sterile water.
- The mixture of the two antibiotics will then be carried into the root canal with special applicators so that the entire root canal is filled with the antibiotics.
- The root canal will then be hermetically sealed with a glass ionomer cement to prevent any coronal leakage or contamination of the root canal with oral microorganisms. The patient will then be discharged and an appointment made for two weeks later.
Second Treatment Visit:
- Local analgesia will be administered and the tooth will be isolated and re-accessed as described above.
- The antibiotic mixture will be flushed out of the root canal by irrigation with normal saline. Following this the root canal will be thoroughly dried with paper points.
- This will then be followed by insertion of a sterile 23-gauge needle with a length of 2 mm beyond the working length and past the confines of the root canal into the periapical tissues to intentionally induce bleeding into the root canal. The bleeding is then allowed to fill the root canal.
- Once the root canal is filled with blood, a cotton pledget will be placed in the pulp chamber and a clot will be allowed to form in the root canal.
- Once the clot has formed the pulp chamber in the coronal part will be thoroughly cleaned to remove any remnants of the blood, which could cause discolouration in the future.
- The access cavity will then be hermetically sealed with three layers of material to prevent coronal leakage and contamination; Portland cement, followed by glass ionomer and then composite resin.
- Patients will then be reviewed after 3, 6 and 9 months.
Review visits and outcomes The patients will be reviewed after 3, 6, 9 and , 12 months, 2 years and 3 years.
The following outcomes will be assessed:
Clinical:
The following will be assessed:
- Presence of normal physiologic tooth mobility.
- Tenderness to percussion.
- Free from pain or discomfort.
- No evidence of labial swelling signifying continued presence of infection.
Radiographic:
Standardised periapical radiographs will be taken before start of treatment, during the treatment and then again at 3 months,and after 9 months, 2 years and 3 years.
Trained independent examiners:
Two trained and independent examiners will evaluate the radiographs. All radiographs will be randomly shown to the examiners who will be independently asked to score the test parameters.
Image analysis:
Continuous root development, changes in dentinal root thickness and apical foramen width will be quantified.
Pulp Sensibility Tests:
At each recall pulp sensibility responses will be evaluated using thermal test (Ethyl Chloride) and Electric Pulp test (EPT).
Photographs:
Standardised intra-oral photographs will be taken before start of the treatment, 9-month, 2 years, and 3 years follow-up visits. Favourable post treatment crown colour in comparison to the pre operative photographs and to that of the contralateral tooth will be assessed using the MathWorks software as described in the study by Day et al. in 2011.
- Conditions
- Tooth Injuries, Endodontically Treated Teeth
- Being tested
- RET using Ciprofloxacin 100mg, and Metronidazole 100mg.
- Keywords
- Non Vital teeth, Traumatised teeth, Immature teeth, Regenerative Endodontics
- Medical subject headings
- Tooth Injuries, Tooth, Nonvital
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
RET using Ciprofloxacin 100mg, and Metronidazole 100mg.Procedure or surgery
First Treatment Visit: Tooth isolation, access, pulp extirpation and root canal irrigation with 0.5% sodium hypochlorite. Canal negotiation, canal drying using paper points. Delivery of the Bi antibiotic paste (mixture of Bi antibiotic paste (Ciprofloxacin 100mg and Metronidazole 100mg with sterile water). Sealing tooth access with glass ionomer cement.
Second Treatment Visit: Tooth analgesia using plain local analgesics, isolatation and re-access as described above. Irrigation of root canal system using normal saline followed by paper point dying. Initiation of bleeding through insertion of a sterile 23-gauge needle with a length of 2 mm beyond the working length into the periapical tissues. Access sealed using Portland cement, followed by glass ionomer and then composite resin.
| Study group | Role | What they receive |
|---|---|---|
| Treatment Group | Experimental | RET using Ciprofloxacin 100mg, and Metronidazole 100mg. Receives: Procedure: RET using Ciprofloxacin 100mg, and Metronidazole 100mg. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in root length
Root length from cement enamel junction to radiographic apex measured over time
Measured: Month 3, Month 9, Year 2, and year 3.
Change in root dentinal wall width
Root dentinal width measured radiographically at 2/3 root length over time
Measured: Month 3, Month 9, Year 2, and year 3.
Change in apical foramen width
Apical foramen width measured radiographically over time
Measured: Month 3, Month 9, Year 2, and year 3.
Change in periodontal healing
Absence of signs and symptoms of infection over time
Measured: Month 3, Month 6, Month 9, Year 2, and year 3.
Secondary outcomes (1)
Change in crown Colour
Crown colour change measured using CIELAB scores
Measured: Month 3,Month 12, year 2, and year 3.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Feb 2017 (estimated)
- Study start1 Jan 2013
- Primary completion1 Jan 2015
- Study completion1 Jan 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Tooth InjuriesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- Prospective interventional uncontrolled trial
- Masking
- None (open label)
- Enrolment
- 15 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Leeds
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Hani Nazzal, University of Leeds
- Investigators
- Hani Nazzal, BDS, PhD, Principal investigator, University of Leeds, School of Dentistry, Paediatric Dentistry Department
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03045185
- Sponsor's protocol ID
- REC 12/YH0488
- Status last verified
- Feb 2017
- First submitted
- 31 Jan 2017
- Last updated
- 8 Feb 2017
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Not planning on IPD
Study at a glance
From the registry record, last updated by the sponsor on 8 Feb 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Prospective Clinical Study of Regenerative Endodontic Treatment of Traumatised Non-vital Immature Teeth Using Bi-antibiotic Paste
- ClinicalTrials.gov ID
- NCT03045185
- Acronym / sponsor ID
- REC 12/YH0488
- Conditions
- Tooth Injuries, Endodontically Treated Teeth
- Keywords
- Non Vital teeth, Traumatised teeth, Immature teeth, Regenerative Endodontics
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 15 participants (actual)
- Lead sponsor
- University of LeedsUniversity, hospital or other
- Study start
- 1 Jan 2013 (actual)
- Primary completion
- 1 Jan 2015 (actual)
- Study completion
- 1 Jan 2017 (actual)
- First posted
- 7 Feb 2017 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Aim: The aim of this prospective study was to evaluate the treatment outcomes of regenerative endodontic technique (RET) for the management of traumatised non-vital immature teeth in children. Methodology: This study aims to recruit 25-30 healthy children with traumatised non-vital immature upper incisors to be treated with bi-antibiotic regenerative endodontic technique. Patients will be reviewed clinically at 3m,6m,9m,12m,2y,and 3 years and radiographically at 3m,9m, 2y,and 3 years. One operator will undertake all treatments, clinical reviews and standardised radiographic exposures. Radiographic analysis will be carried out by two calibrated experienced clinicians. Standardised photographs will be taken at 3m,12m,2y,and 3 years and crown colour changes will be assessed using a standardised validated methodology.
Detailed description
Aims of the pilot study:
Primary:
- Study the clinical and radiographic success of Regenerative Endodontic Technique for the regeneration/revascularisation of immature permanent teeth with necrotic root canal systems following a traumatic injury.
- Study the qualitative and quantitative increase in root dimensions, following RET, by evaluating continued root development and thickening of dentinal walls.
Secondary:
Evaluate effect of treatment on colour change of the treated tooth compared with the healthy contralateral tooth.
Hypothesis:
Through the repopulation of the root canal space with vital tissue, Regenerative Endodontic Technique would promote continued root development and/or thickening of the dentinal walls, thereby improving the long-term prognosis of non vital immature traumatised teeth.
Methodology:
Design of the pilot study:
This will be a prospective interventional study.
Participants:
This study aims to recruit 25-30 patients. This estimation is based on discussion with the statistician and an estimation of the number of children who are referred to the LDI with non-vital immature anterior teeth following trauma, who might be eligible for participation in the study. Ethical approval will be sought through the Integrated Research Application System (IRAS). Patients referred to the Paediatric Dentistry Department at the Leeds Dental Institute (LDI) will be assessed by the clinicians for suitability for inclusion into this study based on the following inclusion and exclusion criteria.
Intervention:
At the RET clinic and once an informed consent is obtained, the treatment will be carried out over two visits each lasting about 45 minutes. During these visits, patients received the following treatment:
First Treatment Visit:
- Preoperative photographs will be taken by the principal investigator using a Fujifilm (Tokyo, Japan), Finepix S3 Pro camera with 105-mm Micro Nikon (Tokyo, Japan) f2.8 lens and sigma ring flash, EM-140DG.
- The tooth will be isolated using dry dam (Directa, Upplands Visby, Sweden).
- The tooth will be accessed and the pulp will be extirpated. The root canal system will then be irrigated with copious chemical disinfectant ( 0.5% sodium hypochlorite) for 15 minutes.
- The canal will then be negotiated with minimal or no filing to prevent further weakening of the existing dentinal walls.
- The canal will then be dried using paper points.
- In an ante-room, the two antibiotics, Ciprofloxacin and Metronidazole, will be mixed with sterile water.
- The mixture of the two antibiotics will then be carried into the root canal with special applicators so that the entire root canal is filled with the antibiotics.
- The root canal will then be hermetically sealed with a glass ionomer cement to prevent any coronal leakage or contamination of the root canal with oral microorganisms. The patient will then be discharged and an appointment made for two weeks later.
Second Treatment Visit:
- Local analgesia will be administered and the tooth will be isolated and re-accessed as described above.
- The antibiotic mixture will be flushed out of the root canal by irrigation with normal saline. Following this the root canal will be thoroughly dried with paper points.
- This will then be followed by insertion of a sterile 23-gauge needle with a length of 2 mm beyond the working length and past the confines of the root canal into the periapical tissues to intentionally induce bleeding into the root canal. The bleeding is then allowed to fill the root canal.
- Once the root canal is filled with blood, a cotton pledget will be placed in the pulp chamber and a clot will be allowed to form in the root canal.
- Once the clot has formed the pulp chamber in the coronal part will be thoroughly cleaned to remove any remnants of the blood, which could cause discolouration in the future.
- The access cavity will then be hermetically sealed with three layers of material to prevent coronal leakage and contamination; Portland cement, followed by glass ionomer and then composite resin.
- Patients will then be reviewed after 3, 6 and 9 months.
Review visits and outcomes The patients will be reviewed after 3, 6, 9 and , 12 months, 2 years and 3 years.
The following outcomes will be assessed:
Clinical:
The following will be assessed:
- Presence of normal physiologic tooth mobility.
- Tenderness to percussion.
- Free from pain or discomfort.
- No evidence of labial swelling signifying continued presence of infection.
Radiographic:
Standardised periapical radiographs will be taken before start of treatment, during the treatment and then again at 3 months,and after 9 months, 2 years and 3 years.
Trained independent examiners:
Two trained and independent examiners will evaluate the radiographs. All radiographs will be randomly shown to the examiners who will be independently asked to score the test parameters.
Image analysis:
Continuous root development, changes in dentinal root thickness and apical foramen width will be quantified.
Pulp Sensibility Tests:
At each recall pulp sensibility responses will be evaluated using thermal test (Ethyl Chloride) and Electric Pulp test (EPT).
Photographs:
Standardised intra-oral photographs will be taken before start of the treatment, 9-month, 2 years, and 3 years follow-up visits. Favourable post treatment crown colour in comparison to the pre operative photographs and to that of the contralateral tooth will be assessed using the MathWorks software as described in the study by Day et al. in 2011.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- Prospective interventional uncontrolled trial
| Arm | Type | Receives |
|---|---|---|
| Treatment Group | Experimental | Procedure: RET using Ciprofloxacin 100mg, and Metronidazole 100mg.RET using Ciprofloxacin 100mg, and Metronidazole 100mg. |
Who may qualify
- Ages
- 6 to 16 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
Key inclusion criteria (8 listed)
- Patients aged 6-16 years of age
- Patients who are fit and healthy or with an ASA1 or ASA2 medical conditions
- Patients with cooperation level that would allow treatment under local analgesia
- Patients with a traumatised permanent incisors, canines or premolars having at least one of the following:
- Patients with permanent incisors, canines or premolars that have incomplete root formation with open apices.
Key exclusion criteria (7 listed)
- Patient older than 16 year of age
- Patients allergic to Ciprofloxacin, Metronidazole.
- Patients with medical conditions and/or receiving medications that would affect patients' body's ability to heal such as diabetic patients or ability of the patients' blood to clot such as patients with Von Willebrand's disease.
- Patients with risk of developing infective endocarditis or immune compromised patients.
- Patients with non traumatised non-vital permanent incisors, canines or premolars where root development already deemed to be completed.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| RET using Ciprofloxacin 100mg, and Metronidazole 100mg.First Treatment Visit: Tooth isolation, access, pulp extirpation and root canal irrigation with 0.5% sodium hypochlorite. Canal negotiation, canal drying using paper points. Delivery of the Bi antibiotic paste (mixture of Bi antibiotic paste (Ciprofloxacin 100mg and Metronidazole 100mg with sterile water). Sealing tooth access with glass ionomer cement. Second Treatment Visit: Tooth analgesia using plain local analgesics, isolatation and re-access as described above. Irrigation of root canal system using normal saline followed by paper point dying. Initiation of bleeding through insertion of a sterile 23-gauge needle with a length of 2 mm beyond the working length into the periapical tissues. Access sealed using Portland cement, followed by glass ionomer and then composite resin. | Procedure or surgery | Treatment Group |
Primary outcome
Change in root length
Time frame: Month 3, Month 9, Year 2, and year 3.
Root length from cement enamel junction to radiographic apex measured over time
Change in root dentinal wall width
Time frame: Month 3, Month 9, Year 2, and year 3.
Root dentinal width measured radiographically at 2/3 root length over time
Change in apical foramen width
Time frame: Month 3, Month 9, Year 2, and year 3.
Apical foramen width measured radiographically over time
Change in periodontal healing
Time frame: Month 3, Month 6, Month 9, Year 2, and year 3.
Absence of signs and symptoms of infection over time
1 secondary outcome
Change in crown Colour
Time frame: Month 3,Month 12, year 2, and year 3.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Feb 2017.
- Individual participant dataSharing planned: No. Not planning on IPD
Related trials for Tooth Injuries
RecruitingPhase 2
Study on Thiamine Supplementation to REduce braiN Injury Associated With Chronic Alcohol Use in Outpatients With Alcohol Use Disorder
Alcohol Use Disorder
Not yet recruiting
Safety Assessment of Placing a Single Dental Implant Without Antibiotic Prophylaxis in Simple Cases: A Pilot Study
Tooth Loss and Rehabillitation, Dental Implant Failure
Not yet recruitingObservational study
Blood NfL and Functional Outcomes After Moderate-to-Severe TBI
Traumatic Brain Injury
Recruiting
Effect of Curcumin Topical Spray on Wound Healing After Tooth Extraction
Wound Healing, Alveolitis of Jaw
Active, not recruiting
Luting Cements for Prefabricated Zirconia Crown Retention in Primary Anterior Teeth in Children
Dental Caries, Tooth Injuries
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Hani Nazzal, BDS, PhD principal investigator
University of Leeds, School of Dentistry, Paediatric Dentistry Department
Questions about this trial
What is this clinical trial studying?
A study testing RET using Ciprofloxacin 100mg, and Metronidazole 100mg. in people with Tooth Injuries and Endodontically Treated Teeth, run by University of Leeds.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 8 Feb 2017. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in root length (time frame: Month 3, Month 9, Year 2, and year 3.). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Feb 2017.